Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

Swiss Cancer Institute · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
breast-cancer
breast cancer, early er+/her2- breast cancer, neodoxy, doxycycline, human epidermal growth factor receptor 2 negative, estrogen receptor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 968693
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.